Skip to content

Depression: all studies

Page 925 of 1,036: studies 9,241 to 9,250 of 10,358, newest first. Back to the depression overview

Research

Dissociation mediates the relationship between peer victimization and hallucinatory experiences among early adolescents.

Schizophrenia research. Cognition May 16, 2016 Syudo Yamasaki, Shuntaro Ando, Shinsuke Koike et al.

Peer victimization increases the risk of experiencing psychotic symptoms among clinical and general populations, but the mechanism underlying this association remains unclear. Dissociation, which is related to peer victimization and hallucinatory experiences, has been demonstrated as a significant mediator in the relation between childhood victimization and hallucinatory experience among adult...

DOI: 10.1016/j.scog.2016.04.001 (opens in new tab) Full text (opens in new tab) Trauma Mediator Bullying Psychotic-like experience

Religious Experience from a Neuro-Psychological View

Kanz Philosophia: A Journal for Islamic Philosophy and Mysticism May 7, 2016 Hadi Vakili

The search for the basis of religious experience among neurological processes in the brain has resulted in a widespread debate within, as well as outside the academic world. The aim of this paper is to analyze to what extent a neuro-psychological theory could explain the phenomenon of religious experience. To clarify what the neuro-psychological studies of the present paper mean by the concept...

DOI: 10.20871/kpjipm.v1i1.6 (opens in new tab) Full text (opens in new tab) Mysticism Religious experience Religious erlebnis Religious erfahrung +8

Δ(9)-Tetrahydrocannabinol-like effects of novel synthetic cannabinoids in mice and rats.

Psychopharmacology May 2016 Michael B. Gatch, Michael J Forster

Novel cannabinoid compounds continue to be marketed as "legal" marijuana substitutes, even though little is known about their molecular and behavioral effects. Six of these compounds (ADBICA, ADB-PINACA, THJ-2201, RCS-4, JWH-122, JWH-210) were tested for in vitro and in vivo cannabinoid-like effects to determine their abuse liability. Binding to and functional activity at CB1 cannabinoid...

DOI: 10.1007/s00213-016-4237-6 (opens in new tab) Full text (opens in new tab) Abuse liability Cannabinoids Drug discrimination Locomotor activity +2

CANNABIS (BHANG, CHARAS) CONSUMPTION; EMOTIONAL AND COGNITIVE DISTURBANCES AND DEPRESSIVE SYMPTOMS IN YOUNG ADULTS

The Professional Medical Journal May 1, 2016 Fauzia Naz 2 citations

Cannabis or marijuana is an illegal drug that is being used mostly by young adultscan have adverse effects i.e., dependence syndrome, impaired respiratory and cardiovascularfunctions, psychosocial and mental health disorders. Objective: The present study examinedthe effects of cannabis (including bhang & charas) consumption on emotional and cognitivedisturbances and depressive symptoms in young...

Ketamine: stimulating antidepressant treatment?

BJPsych Open May 1, 2016 Gin S. Malhi, Yulisha Byrow, Frederick Cassidy et al. 31 citations

SUMMARY: The appeal of ketamine - in promptly ameliorating depressive symptoms even in those with non-response - has led to a dramatic increase in its off-label use. Initial promising results await robust corroboration and key questions remain, particularly concerning its long-term administration. It is, therefore, timely to review the opinions of mood disorder experts worldwide pertaining to...

Preliminary Investigation of a Mindfulness-Based Intervention for Social Anxiety Disorder That Integrates Compassion Meditation and Mindful Exposure.

The Journal of Alternative and Complementary Medicine May 1, 2016 Diana Koszycki, Jennifer Thake, Céline Mavounza et al.

This study evaluated the feasibility and initial efficacy of a 12-week group mindfulness-based intervention tailored for persons with social anxiety disorder (MBI-SAD). The intervention includes elements of the standard mindfulness-based stress reduction program, explicit training in self-compassion aimed at cultivating a more accepting and kinder stance toward oneself, and use of exposure...

Quantum neurophysics: From non-living matter to quantum neurobiology and psychopathology.

International Journal of Psychophysiology May 1, 2016 Sultan Tarlacı, Massimo Pregnolato

The concepts of quantum brain, quantum mind and quantum consciousness have been increasingly gaining currency in recent years, both in scientific papers and in the popular press. In fact, the concept of the quantum brain is a general framework. Included in it are basically four main sub-headings. These are often incorrectly used interchangeably. The first of these and the one which started the...

DOI: 10.1016/j.ijpsycho.2015.02.016 (opens in new tab) Full text (opens in new tab) Consciousness Measurement problem Psychopathology Quantum biology +2

Efficacy of Mindfulness-Based Cognitive Therapy in Prevention of Depressive Relapse

JAMA Psychiatry April 28, 2016 Willem Kuyken, Fiona C Warren, Rod S. Taylor et al. 815 citations

IMPORTANCE: Relapse prevention in recurrent depression is a significant public health problem, and antidepressants are the current first-line treatment approach. Identifying an equally efficacious nonpharmacological intervention would be an important development. OBJECTIVE: To conduct a meta-analysis on individual patient data to examine the efficacy of mindfulness-based cognitive therapy...

DOI: 10.1001/jamapsychiatry.2016.0076 (opens in new tab) Full text (opens in new tab) Psycinfo Mindfulness-based cognitive therapy Medline Randomized controlled trial +4

Editorial: Neural Mechanisms Underlying Movement-Based Embodied Contemplative Practices

Frontiers in Human Neuroscience April 26, 2016 Laura Schmalzl, C. Kerr 18 citations

Compared to the extensive body of neuroscientific work on seated meditation practices, far fewer studies have investigated the neural mechanisms underlying movement-based contemplative practices such as yoga or tai chi. One likely reason is the inherent challenge of dealing with their multifaceted nature, typically involving specific movement sequences, regulation of the breath, and modulation...

NMDAR inhibition-independent antidepressant actions of ketamine metabolites

Nature April 24, 2016 Panos Zanos, Ruin Moaddel, Patrick J. Morris et al. 1,602 citations

Major depressive disorder affects around 16 per cent of the world population at some point in their lives. Despite the availability of numerous monoaminergic-based antidepressants, most patients require several weeks, if not months, to respond to these treatments, and many patients never attain sustained remission of their symptoms. The non-competitive, glutamatergic NMDAR (N-methyl-d-aspartate...